Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anna V Lomonosova"'
Autor:
Anna V Lomonosova, Andrei B Ulitin, Alexei S Kazakov, Tajib A Mirzabekov, Eugene A Permyakov, Sergei E Permyakov
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0170349 (2017)
Small antibody mimetics, or alternative binding proteins (ABPs), extend and complement antibody functionality with numerous applications in research, diagnostics and therapeutics. Given the superiority of ABPs, the last two decades have witnessed dev
Externí odkaz:
https://doaj.org/article/b2cb9c993d7741e0838077d0271c1463
Autor:
Anna V Lomonosova, Elena V Ovchinnikova, Alexei S Kazakov, Alexander I Denesyuk, Alexander D Sofin, Roman V Mikhailov, Andrei B Ulitin, Tajib A Mirzabekov, Eugene A Permyakov, Sergei E Permyakov
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0134906 (2015)
Due to their remarkably high structural stability, proteins from extremophiles are particularly useful in numerous biological applications. Their utility as alternative protein scaffolds could be especially valuable in small antibody mimetic engineer
Externí odkaz:
https://doaj.org/article/69dc8a9ab4a84808b4790602bfa4e9e2
Autor:
Alexei S. Kazakov, Anna V. Lomonosova, Ulitin Andrei Borisovich, Tajib Mirzabekov, Sergei E. Permyakov, Eugene A. Permyakov
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 1, p e0170349 (2017)
PLoS ONE, Vol 12, Iss 1, p e0170349 (2017)
Small antibody mimetics, or alternative binding proteins (ABPs), extend and complement antibody functionality with numerous applications in research, diagnostics and therapeutics. Given the superiority of ABPs, the last two decades have witnessed dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49758741475bcea1d0650477e365778f
http://europepmc.org/articles/PMC5245882
http://europepmc.org/articles/PMC5245882
Autor:
Fedor Brovko, A. G. Laman, Anna V. Lomonosova, K. K. Fursova, E. V. Grishin, A. O. Shepelyakovskaya, Yury V. Vertiev
A method for generation of highly specific miniantibodies within the phage particle has been developed, and used to produce antibodies against Staphylococcus enterotoxin type C1. Under successive panning of the non-immune phage miniantibody (scFv) li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcda3783352777c3a6819322720de5ff
https://europepmc.org/articles/PMC3242837/
https://europepmc.org/articles/PMC3242837/
